| 2023-01-17 | -72.7% | news | Seeking Alpha | Viveve crashes ~60% as company decides to delist, explore sale after trial fails |
| 2023-01-17 | -72.7% | legal | SEC EDGAR | VIVE 8-K: 2.05, 3.01, 8.01 (SEC Filing) |
| 2023-01-17 | -72.7% | news | Seeking Alpha | Viveve crashes ~60% as company decides to delist, explore sale after trial fails - Seeking Alpha |
| 2022-03-17 | +22.6% | earnings | Seeking Alpha | Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript |
| 2022-03-17 | +22.6% | earnings | Seeking Alpha | Viveve Medical GAAP EPS of -$2.65 misses by $0.13, revenue of $6.43M beats by $0.01M |
| 2022-03-17 | +22.6% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2022-03-16 | +18.7% | earnings | Seeking Alpha | Viveve Medical FY 2021 Earnings Preview |
| 2022-01-21 | -13.8% | legal | SEC EDGAR | VIVE 8-K: 5.02 and (SEC Filing) |
| 2022-11-10 | -10.2% | earnings | Seeking Alpha | Viveve Medical GAAP EPS of -$0.59 beats by $0.07, revenue of $17M beats by $15.29M |
| 2022-11-10 | -10.2% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2022-11-11 | -10.0% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript |
| 2022-12-20 | -9.1% | news | GuruFocus | Mark R Tauscher Net Worth (2026) - GuruFocus |
| 2021-06-25 | +9.1% | legal | SEC EDGAR | VIVE 8-K: 5.02 and 5.07 (SEC Filing) |
| 2022-08-10 | +8.1% | earnings | Seeking Alpha | Viveve Medical Q2 2022 Earnings Preview |
| 2021-05-13 | -6.7% | earnings | Seeking Alpha | Viveve Medical EPS misses by $0.29, beats on revenue |
| 2021-05-13 | -6.7% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2023-03-23 | -6.7% | news | TradingView | VIVE Stock Price and Chart — OTC:VIVE - TradingView |
| 2022-08-11 | +4.3% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript |
| 2022-08-11 | +4.3% | earnings | Seeking Alpha | Viveve Medical GAAP EPS of -$0.67 in-line, revenue of $1.8M beats by $0.04M |
| 2022-08-11 | +4.3% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2022-10-04 | -4.2% | news | Seeking Alpha | Viveve to get US patent for technology to treat female stress urinary incontinence |
| 2022-05-13 | +3.4% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript |
| 2021-05-11 | -2.6% | legal | SEC EDGAR | VIVE 8-K: 8.01 and (SEC Filing) |
| 2022-09-30 | -2.6% | news | Seeking Alpha | Viveve Medical (VIVE) Investor Presentation - Slideshow |
| 2021-08-12 | -2.5% | earnings | Seeking Alpha | Viveve Medical EPS beats by $0.16, beats on revenue |
| 2021-08-12 | -2.5% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2021-08-13 | -2.1% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript |
| 2021-11-12 | -1.7% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript |
| 2021-11-12 | -1.7% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2022-05-12 | +1.7% | earnings | Seeking Alpha | Viveve Medical GAAP EPS of -$0.67 beats by $0.01, revenue of $1.64M beats by $0.03M |
| 2022-05-12 | +1.7% | legal | SEC EDGAR | VIVE 8-K: 2.02 and (SEC Filing) |
| 2022-05-11 | -1.5% | earnings | Seeking Alpha | Viveve Medical Q1 2022 Earnings Preview |
| 2021-11-11 | -1.3% | earnings | Seeking Alpha | Viveve Medical EPS misses by $0.10, misses on revenue |
| 2022-12-06 | +1.2% | news | GuruFocus | Steven L Basta Net Worth (2026) - GuruFocus |
| 2021-11-10 | -1.1% | earnings | Seeking Alpha | Viveve Medical Q3 2021 Earnings Preview |
| 2021-06-02 | -0.9% | legal | SEC EDGAR | VIVE 8-K: 8.01 and (SEC Filing) |
| 2021-05-14 | +0.8% | earnings | Seeking Alpha | Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript |
| 2025-04-25 | -0.8% | news | Stock Titan | BIIO Stock Price, News & Analysis - Stock Titan |
| 2022-11-15 | -0.7% | news | GuruFocus | Mark Samuel Colella Net Worth (2026) - GuruFocus |
| 2022-07-12 | +0.5% | news | Seeking Alpha | Viveve Medical receives patent for dual-energy technology in Taiwan |
| 2026-03-13 | -0.4% | news | Meyka | VIVE (Viveve Medical) NASDAQ pre-market up 19,900% on 13 Mar 2026: top gainer insight - Meyka |